GW Pharma (GWPH) Posts Smaller-than-Expected Q1 Loss

GW Pharma (NASDAQ: GWPH) reported Q1 EPS of ($0.77), $0.92 better than the analyst estimate of ($1.69). Revenue for the quarter came in at $2.54 million versus the consensus estimate of $2.4 million.

For earnings history and earnings-related data on GW Pharma (GWPH) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
• Onto Innovation gains on bullish RBC initiation citing advanced packaging growth